These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. Zileuton Study Group. Liu MC, Dubé LM, Lancaster J. J Allergy Clin Immunol; 1996 Nov; 98(5 Pt 1):859-71. PubMed ID: 8939149 [Abstract] [Full Text] [Related]
3. Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group. Israel E, Cohn J, Dubé L, Drazen JM. JAMA; 1996 Mar 27; 275(12):931-6. PubMed ID: 8598621 [Abstract] [Full Text] [Related]
4. Effects of single-dose zileuton on bronchial hyperresponsiveness in asthmatic patients treated with inhaled corticosteroids. Dekhuijzen PN, Bootsma GP, Wielders PL, van den Berg LR, Festen J, van Herwaarden CL. Eur Respir J; 1997 Dec 27; 10(12):2749-53. PubMed ID: 9493655 [Abstract] [Full Text] [Related]
5. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. Dahlén SE, Malmström K, Nizankowska E, Dahlén B, Kuna P, Kowalski M, Lumry WR, Picado C, Stevenson DD, Bousquet J, Pauwels R, Holgate ST, Shahane A, Zhang J, Reiss TF, Szczeklik A. Am J Respir Crit Care Med; 2002 Jan 01; 165(1):9-14. PubMed ID: 11779723 [Abstract] [Full Text] [Related]
10. Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma. Fischer AR, Rosenberg MA, Lilly CM, Callery JC, Rubin P, Cohn J, White MV, Igarashi Y, Kaliner MA, Drazen JM. J Allergy Clin Immunol; 1994 Dec 01; 94(6 Pt 1):1046-56. PubMed ID: 7798537 [Abstract] [Full Text] [Related]
11. Randomized trial of zileuton in patients with moderate asthma: effect of reduced dosing frequency and amounts on pulmonary function and asthma symptoms. Zileuton Study Group. DuBuske LM, Grossman J, Dubé LM, Swanson LJ, Lancaster JF. Am J Manag Care; 1997 Apr 01; 3(4):633-40. PubMed ID: 10169531 [Abstract] [Full Text] [Related]
17. Changes in urinary LTE4 and nasal functions following nasal provocation test with ASA in ASA-tolerant and -intolerant asthmatics. Micheletto C, Tognella S, Visconti M, Trevisan F, Dal Negro RW. Respir Med; 2006 Dec 01; 100(12):2144-50. PubMed ID: 16678396 [Abstract] [Full Text] [Related]
19. The effect of ABT-761, a novel 5-lipoxygenase inhibitor, on exercise- and adenosine-induced bronchoconstriction in asthmatic subjects. Van Schoor J, Joos GF, Kips JC, Drajesk JF, Carpentier PJ, Pauwels RA. Am J Respir Crit Care Med; 1997 Mar 01; 155(3):875-80. PubMed ID: 9117020 [Abstract] [Full Text] [Related]
20. The 5-lipoxygenase inhibitor zileuton blocks antigen-induced late airway responses, inflammation and airway hyperresponsiveness in allergic sheep. Abraham WM, Ahmed A, Cortes A, Sielczak MW, Hinz W, Bouska J, Lanni C, Bell RL. Eur J Pharmacol; 1992 Jul 07; 217(2-3):119-26. PubMed ID: 1330588 [Abstract] [Full Text] [Related] Page: [Next] [New Search]